496
Views
13
CrossRef citations to date
0
Altmetric
Review

An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?

ORCID Icon, , , &
Pages 43-54 | Received 15 Sep 2017, Accepted 25 Oct 2017, Published online: 03 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Maria Gabriella Matera, Luigino Calzetta, Rosa Annibale, Francesco Russo & Mario Cazzola. (2021) Classes of drugs that target the cellular components of inflammation under clinical development for COPD. Expert Review of Clinical Pharmacology 14:8, pages 1015-1027.
Read now
Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2020) The role of triple therapy in the management of COPD. Expert Review of Clinical Pharmacology 13:8, pages 865-874.
Read now
Maria Gabriella Matera, Luigino Calzetta, Ermanno Puxeddu, Paola Rogliani & Mario Cazzola. (2018) A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD. Expert Opinion on Drug Safety 17:5, pages 509-517.
Read now

Articles from other publishers (10)

Mei‐Feng Chen, Wei He, De‐Sheng Huang, Hui Jia, Zhao‐Shuang Zhong, Nan Li, Shan‐Shan Li & Shu‐Yue Xia. (2023) Effects of doxofylline as an adjuvant on severe exacerbation and long‐term prognosis for COPD with different clinical subtypes. The Clinical Respiratory Journal 17:9, pages 851-864.
Crossref
Mario Cazzola, Paola RoglianiPeter J. BarnesFrancesco BlasiBartolome Celli, Nicola A. HananiaFernando J. MartinezBruce E. MillerMarc Miravitlles, Clive P. PageRuth Tal-Singer & Maria Gabriella Matera. (2023) An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials. American Journal of Respiratory and Critical Care Medicine 208:4, pages 374-394.
Crossref
Jianghong Chen, Zhaohui Zhong, Wei Wang, Ganggang Yu, Tingting Zhang & Zhenchang Wang. (2022) Quantitative evaluation of diaphragmatic motion during forced breathing in chronic obstructive pulmonary disease patients using dynamic chest radiography. Frontiers in Integrative Neuroscience 16.
Crossref
Loganathan Nattusami, Vijay Hadda, GopiC Khilnani, Karan Madan, Saurabh Mittal, Pawan Tiwari, Anant Mohan, MaroofAhmad Khan & Randeep Guleria. (2021) Co-existing obstructive sleep apnea among patients with chronic obstructive pulmonary disease. Lung India 38:1, pages 12.
Crossref
K. L. Nikolaieva. (2020) Dynamics of Inflammatory Markers in Patients with Pulmonary Hypertension on the Background of COPD combined with Hypertension under the Influence of Treatment. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 5:6, pages 150-157.
Crossref
Maliha Zahid, Timothy N. Feinstein, Anthony Oro, Molly Schwartz, Alex D. Lee & Cecilia W. Lo. (2020) Rapid Ex-Vivo Ciliogenesis and Dose-Dependent Effect of Notch Inhibition on Ciliogenesis of Respiratory Epithelia. Biomolecules 10:8, pages 1182.
Crossref
Nevin Kishore, Saibal Moitra & Mrinal Sircar. (2020) Management of chronic obstructive pulmonary disease: Insights into patient profile – Use of inhaled corticosteroids/long-acting β 2 -Agonists or long-acting β 2 -agonists/long-acting muscarinic antagonists . Indian Journal of Respiratory Care 9:2, pages 162.
Crossref
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta & Mario Cazzola. (2020) Triple Combination Inhalers in Chronic Obstructive Pulmonary Disease and Asthma. US Respiratory & Pulmonary Diseases 5:1, pages 18.
Crossref
Mario Cazzola, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2019) Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses. Pulmonary Therapy 5:2, pages 117-126.
Crossref
Mario Cazzola, Paola Rogliani, Daiana Stolz & Maria Gabriella Matera. (2019) Pharmacological treatment and current controversies in COPD. F1000Research 8, pages 1533.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.